Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque.

The serum determination of gamma-glutamyltransferase (γ-GT) activity is a low-cost, highly sensitive and accurate, and frequently used laboratory test. Although it is considered to be an index of hepatobiliary dysfunction and alcohol abuse,1 recent epidemiology and pathology studies have suggested its independent role in the pathogenesis and clinical evolution of cardiovascular diseases brought on by atherosclerosis.1,2 Article p 2130 The prospective study by Ruttman and colleagues in 163 944 Austrian adults studied for 17 years shows that γ-GT is independently associated with cardiovascular mortality.3 Serum γ-GT activity had a prognostic impact on fatal events of chronic forms of coronary heart disease, congestive heart failure, and ischemic or hemorrhagic stroke. This was found to be true in both sexes, with a clear dose-response relationship, and with a stronger prognostic significance of γ-GT in younger participants. These findings from a large unselected cohort unequivocally confirm previous observations that γ-GT is associated with overall mortality and cardiovascular events, in both unselected populations4–7 and patients with ascertained coronary artery disease, independent of all confounders including liver function and alcohol use.8,9 γ-GT is the enzyme responsible for the extracellular catabolism of glutathione (GSH, γ-glutamyl-cisteinyl-glycine), the main thiol intracellular antioxidant agent in mammalian cells.1 It is present, linked through a small lipophilic sequence of its larger subunit, on the cell surface membrane of most cell types; although the same protein is produced in all tissues, differences in the sugar moieties allow that only the liver γ-GT is detectable in serum.10 Most serum γ-GT is bound to carriers, such as α- and β-lipoproteins and albumin.1 This association is likely to occur within hepatocytes, before γ-GT releases in serum, through still-unknown mechanisms. Serum γ-GT activity is affected by genetic and environmental factors, with heritability estimated at 0.52.11 Within its …

[1]  M. Emdin,et al.  β-Lipoprotein- and LDL-associated serum γ-glutamyltransferase in patients with coronary atherosclerosis , 2006 .

[2]  H. Concin,et al.  γ-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults , 2005, Circulation.

[3]  P. Libby,et al.  Pathophysiology of Coronary Artery Disease , 2005, Circulation.

[4]  ClaudioPassino,et al.  Human Atherosclerotic Plaques Contain Gamma-Glutamyl Transpeptidase Enzyme Activity , 2004 .

[5]  N. Martin,et al.  Genetic Covariation between Serum γ-Glutamyltransferase Activity and Cardiovascular Risk Factors , 2002 .

[6]  M. Emdin,et al.  Serum gamma-glutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption. , 2002, Stroke.

[7]  M. Emdin,et al.  Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. , 2001, European heart journal.

[8]  J. Whitfield Gamma Glutamyl Transferase , 2001, Critical reviews in clinical laboratory sciences.

[9]  P. Jousilahti,et al.  Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. , 2000, Stroke.

[10]  J. Herlitz,et al.  Ten‐year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia , 2000, Journal of internal medicine.

[11]  A. Paolicchi,et al.  Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation--a potential mechanism in atherosclerosis. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[12]  J. Salonen,et al.  Association between body iron stores and the risk of acute myocardial infarction in men. , 1998, Circulation.

[13]  H. Brenner,et al.  Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. , 1997, Preventive medicine.

[14]  Y. L. Chen,et al.  Increased ferritin gene expression in atherosclerotic lesions. , 1996, The Journal of clinical investigation.

[15]  S. Ebrahim,et al.  Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. , 1995, American journal of epidemiology.

[16]  J. Whitfield,et al.  Prediction of alcohol-related harm by laboratory test results. , 1993, Clinical chemistry.

[17]  O H Førde,et al.  The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase. , 1990, American journal of epidemiology.

[18]  N. Huseby Multiple forms of serum γ-glutamyltransferase. Association of the enzyme with lipoproteins , 1982 .

[19]  M. Anderson,et al.  Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Emdin,et al.  Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. , 2006, Atherosclerosis.

[21]  A. Pompella,et al.  The significance of serum γ-glutamyltransferase in cardiovascular diseases , 2004, Clinical chemistry and laboratory medicine.

[22]  N. Martin,et al.  Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. , 2002, Clinical chemistry.

[23]  J. Achard,et al.  Serum Gamma-Glutamyltransferase as a Risk Factor of Ischemic Stroke Might Be Independent of Alcohol Consumption Letters to the Editor , 2002 .

[24]  N. Huseby Multiple forms of serum gamma-glutamyltransferase. Association of the enzyme with lipoproteins. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[25]  A. Meister,et al.  Gamma-glutamyl transpeptidase. , 1981, Methods in enzymology.